In contrast, one case initially presented with a mixed-phenotype myeloid sarcoma (CD19 retention with partial MPO acquisition) at first relapse, which then evolved into a complete myeloid sarcoma at second relapse. The gene discussed is CD19; the disease is myeloid sarcoma.